BMI Linked to Risk for Orthostatic Intolerance Post Bariatric Sx

Share this content:
BMI Linked to Risk for Orthostatic Intolerance Post Bariatric Sx
BMI Linked to Risk for Orthostatic Intolerance Post Bariatric Sx

WEDNESDAY, Feb. 1, 2017 (HealthDay News) -- Lower body mass index (BMI) and body fat is associated with increased risk of orthostatic intolerance (OI) and predisposition to noncardiac syncope (NCS) following bariatric surgery, according to research published online Jan. 23 in Obesity Reviews.

Georgios A. Christou, M.D., Ph.D., and Dimitrios N. Kiortsis, M.D., Ph.D., from the University of Ioannina in Greece, and colleagues examined the effects of body weight status on OI and predisposition to NCS.

The researchers found that most cross-sectional studies have shown that the lower the BMI, the greater the predisposition to OI; this was accompanied by down-regulation of sympathetic nervous system activity and up-regulation of activity of the parasympathetic nervous system. These changes were seen across the spectrum of BMI values, and may be associated with central body fat more strongly than total body fat. Increased OI was seen in association with weight loss following bariatric surgery, which was attributed to the effects of weight loss, the specific type of surgical procedure, and the potential postoperative autonomic neuropathy due to vitamin deficiency. For affected individuals, the increased OI rendered bariatric surgery not easily tolerable, with increased fluid and salt intake, pharmacological measures, or surgical adjustments necessary to attenuate OI.

"The relationship between orthostatic responses and body weight status has important implications in the evaluation of the results of studies investigating orthostatic responses and NCS," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »